Redirect Notice
The previous page is sending you to
http://www.businesswire.com/news/home/20140815005610/en/Biogen-Idec%E2%80%99s-PLEGRIDY%E2%84%A2-Peginterferon-Beta-1a-Approved-Treatment
.
If you do not want to visit that page, you can
return to the previous page
.